# Clarithromycin for the Treatment of Hypersomnia

> **NCT01146600** · PHASE2 · COMPLETED · sponsor: **Lynn Marie Trotti** · enrollment: 26 (actual)

## Conditions studied

- Hypersomnia
- Idiopathic Hypersomnia
- Narcolepsy

## Interventions

- **DRUG:** Clarithromycin followed by placebo
- **DRUG:** Placebo then Clarithromycin

## Key facts

- **NCT ID:** NCT01146600
- **Lead sponsor:** Lynn Marie Trotti
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01146600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01146600, "Clarithromycin for the Treatment of Hypersomnia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01146600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*